165 related articles for article (PubMed ID: 37715443)
1. Molecular Subtypes Based on PANoptosis Genes and Characteristics of Immune Infiltration in Cutaneous Melanoma.
Zhong L; Qian W; Gong W; Zhu L; Wang X
Cell Mol Biol (Noisy-le-grand); 2023 Aug; 69(8):1-8. PubMed ID: 37715443
[TBL] [Abstract][Full Text] [Related]
2. PANoptosis-related prognostic signature predicts overall survival of cutaneous melanoma and provides insights into immune infiltration landscape.
Wang W; Zhou Q; Lan L; Xu X
Sci Rep; 2023 May; 13(1):8449. PubMed ID: 37231081
[TBL] [Abstract][Full Text] [Related]
3. PANoptosis subtypes predict prognosis and immune efficacy in gastric cancer.
Liu Z; Sun L; Peng X; Zhu J; Wu C; Zhu W; Huang C; Zhu Z
Apoptosis; 2024 Jun; 29(5-6):799-815. PubMed ID: 38347337
[TBL] [Abstract][Full Text] [Related]
4. A comprehensive analysis of PANoptosome to prognosis and immunotherapy response in pan-cancer.
Zhuang L; Sun Q; Huang S; Hu L; Chen Q
Sci Rep; 2023 Mar; 13(1):3877. PubMed ID: 36890219
[TBL] [Abstract][Full Text] [Related]
5. The PANoptosis-related signature indicates the prognosis and tumor immune infiltration features of gliomas.
Song J; Xu Z; Fan Q; Sun Y; Lin X
Front Mol Neurosci; 2023; 16():1198713. PubMed ID: 37501725
[TBL] [Abstract][Full Text] [Related]
6. Identification of fatty acid metabolism-related molecular subtype biomarkers and their correlation with immune checkpoints in cutaneous melanoma.
Xu Y; Chen Y; Jiang W; Yin X; Chen D; Chi Y; Wang Y; Zhang J; Zhang Q; Han Y
Front Immunol; 2022; 13():967277. PubMed ID: 36466837
[TBL] [Abstract][Full Text] [Related]
7. A novel pyroptosis-related LncRNA signature predicts prognosis and indicates tumor immune microenvironment in skin cutaneous melanoma.
Zhong J; Wang Z; Houssou Hounye A; Liu J; Zhang J; Qi M
Life Sci; 2022 Oct; 307():120832. PubMed ID: 35940218
[TBL] [Abstract][Full Text] [Related]
8. Machine learning-based signature of necrosis-associated lncRNAs for prognostic and immunotherapy response prediction in cutaneous melanoma and tumor immune landscape characterization.
Cui Z; Liang Z; Song B; Zhu Y; Chen G; Gu Y; Liang B; Ma J; Song B
Front Endocrinol (Lausanne); 2023; 14():1180732. PubMed ID: 37229449
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of ferroptosis-related lncRNA signature and immune-related gene signature for predicting the prognosis of cutaneous melanoma patients.
Xiong K; Wang Z; Hounye AH; Peng L; Zhang J; Qi M
Apoptosis; 2023 Jun; 28(5-6):840-859. PubMed ID: 36964478
[TBL] [Abstract][Full Text] [Related]
10. Characteristic of molecular subtypes based on PANoptosis-related genes and experimental verification of hepatocellular carcinoma.
Ren H; Kang N; Yin S; Xu C; Qu T; Dai D
Aging (Albany NY); 2023 May; 15(10):4159-4181. PubMed ID: 37171396
[TBL] [Abstract][Full Text] [Related]
11. Identification of PANoptosis-related predictors for prognosis and tumor microenvironment by multiomics analysis in glioma.
Sun F; Liao M; Tao Z; Hu R; Qin J; Tao W; Liu W; Wang Y; Pi G; Lei J; Bao W; Dong Z
J Cancer; 2024; 15(9):2486-2504. PubMed ID: 38577605
[TBL] [Abstract][Full Text] [Related]
12. Comparative analysis identifies genetic and molecular factors associated with prognostic clusters of PANoptosis in glioma, kidney and melanoma cancer.
Mall R; Kanneganti TD
Sci Rep; 2023 Nov; 13(1):20962. PubMed ID: 38017056
[TBL] [Abstract][Full Text] [Related]
13. PANoptosis-related signature in melanoma: Transcriptomic mapping and clinical prognostication.
Xie J; Zhang P; Xu X; Zhou X; Zhao S; Zhang M; Qi M
Environ Toxicol; 2024 May; 39(5):2545-2559. PubMed ID: 38189554
[TBL] [Abstract][Full Text] [Related]
14. PANoptosis: Emerging mechanisms and disease implications.
Qi Z; Zhu L; Wang K; Wang N
Life Sci; 2023 Nov; 333():122158. PubMed ID: 37806654
[TBL] [Abstract][Full Text] [Related]
15. Pyroptosis-related gene mediated modification patterns and immune cell infiltration landscapes in cutaneous melanoma to aid immunotherapy.
Meng J; Huang X; Qiu Y; Zheng X; Huang J; Wen Z; Yao J
Aging (Albany NY); 2021 Nov; 13(21):24379-24401. PubMed ID: 34753832
[TBL] [Abstract][Full Text] [Related]
16. Identification of a pyroptosis-associated long non-coding RNA signature for predicting the immune status and prognosis in skin cutaneous melanoma.
Wu L; Liu G; He YW; Chen R; Wu ZY
Eur Rev Med Pharmacol Sci; 2021 Sep; 25(18):5597-5609. PubMed ID: 34604952
[TBL] [Abstract][Full Text] [Related]
17. The PANoptosome: A Deadly Protein Complex Driving Pyroptosis, Apoptosis, and Necroptosis (PANoptosis).
Samir P; Malireddi RKS; Kanneganti TD
Front Cell Infect Microbiol; 2020; 10():238. PubMed ID: 32582562
[TBL] [Abstract][Full Text] [Related]
18. Identification of the PANoptosome: A Molecular Platform Triggering Pyroptosis, Apoptosis, and Necroptosis (PANoptosis).
Christgen S; Zheng M; Kesavardhana S; Karki R; Malireddi RKS; Banoth B; Place DE; Briard B; Sharma BR; Tuladhar S; Samir P; Burton A; Kanneganti TD
Front Cell Infect Microbiol; 2020; 10():237. PubMed ID: 32547960
[TBL] [Abstract][Full Text] [Related]
19. Analysis of differential gene immune infiltration and clinical characteristics of skin cutaneous melanoma based on systems biology and drug repositioning methods to identify drug candidates for skin cutaneous melanoma.
Long S; Xu J; Huang H
Naunyn Schmiedebergs Arch Pharmacol; 2023 Oct; 396(10):2427-2447. PubMed ID: 37086280
[TBL] [Abstract][Full Text] [Related]
20. Exploring PANoptosis in breast cancer based on scRNA-seq and bulk-seq.
He P; Ma Y; Wu Y; Zhou Q; Du H
Front Endocrinol (Lausanne); 2023; 14():1164930. PubMed ID: 37455906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
